Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Founded by Harris Fienberg and Mike Angelo in 2014, Ionpath is backed by investors that include Paladin Partners Investments, Samsara BioCapital, Bruker, Genoa Ventures, and Vertical Venture Partners and is headquartered in Menlo Park.
FOUNDED:
2014
INDUSTRY:
Health Care, Health Diagnostics, Medical
FOUNDERS:
Harris Fienberg, Mike Angelo
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
